Female pelvic actinomycosis and intrauterine contraceptive devices

le pelvic actinomycosis and intrauterine contraceptive devices Review (4740) Total Article Views Authors: Faustino R Pérez-López, José J Tobajas, Peter Chedraui Published Date May 2010 Volume 2010:1 Pages 35 - 38 DOI: http://dx.doi.org/10.2147/OAJC.S7476 Faustino R Pérez-López1,2, José J Tobajas1,3, Peter Chedraui4 1Department of Obstetrics and Gynecology, Facultad de Medicina, Universidad de Zaragoza; 2Hospital Clínico Lozano Blesa; 3Hospital Universitario Miguel Servet, Zaragoza, Spain; 4Enrique C. Sotomayor Obstetrics and Gynecology Hospital, Guayaquil, Ecuador Abstract: Female genital Actinomyces infection is relatively rare, although strongly related to long-lasting intrauterine contraceptive device (IUD) application. An infective pathway has been postulated extending upward from the female perineum to the vagina and cervix. The traumatic effect of the device and a prior infection may contribute to the Actinomyces infection in the female genitalia. This disease is characterized by local swelling, suppuration, abscess formation, tissue fibrosis, tubal-ovarian mass and fistula formation. The infection spreads by contiguity often mimicking the characteristics of a malignant neoplastic process. Currently there is no consensus regarding diagnosis and screening tests, although there seems to be agreement in relation to IUD type, duration, and sexual behavior as major risk factors.